Treatment outcomes of patients with HIV and tuberculosis.

ABSTRACT:

Rationale

The optimal length of tuberculosis treatment in patients coinfected with HIV is unknown.

Objectives

To evaluate treatment outcomes for HIV-infected patients stratified by duration of rifamycin-based tuberculosis therapy.

Methods

We retrospectively reviewed data on all patients with tuberculosis reported to the San Francisco Tuberculosis Control Program from 1990 through 2001. Patients were followed for up to 12 months after treatment completion.

Measurements and main results

Of 700 patients, 264 (38%) were HIV infected, 315 (45%) were not infected, and 121 (17%) were not tested. Mean duration of treatment was extended to 10.2 months for HIV-infected patients versus 8.4 months for uninfected/unknown patients (p < 0.001). Seventeen percent of the HIV-in

SUBMITTER: Nahid P 

PROVIDER: S-EPMC1899273 | biostudies-literature | 2007 Jun

REPOSITORIES: biostudies-literature